Syon Capital’s Nu Skin NUS Stock Holding History

Syon Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,190	Closed	-$412K	–	493
2023 Q4	$412K	Buy	21,190 +3,535	+20%	+$65.2K	0.02%	440
2023 Q3	$374K	Buy	+17,655	New	+$459K	0.05%	233

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Syon Capital's NUS Position: Q1 2024 in Review

Syon Capital sold out of Nu Skin (NUS) in Q1 2024, closing a stake of 21,190 shares — an estimated $412K sold.

Syon Capital first reported a position in NUS in Q3 2023 and held it in 2 quarters. The position peaked at $412K in Q4 2023. 198 funds tracked by Wall St. Rank hold NUS as of Q1 2024.

Syon Capital reported no remaining Nu Skin position as of Q1 2024 after selling out during the quarter.
Syon Capital sold 21,190 Nu Skin shares in Q1 2024, an estimated $412K.
Syon Capital first reported a position in Nu Skin in Q3 2023 and held it in 2 quarters.
Syon Capital's Nu Skin position peaked at $412K in Q4 2023.
198 funds tracked by Wall St. Rank held Nu Skin as of Q1 2024.

Based on Syon Capital's 13F filing for Q1 2024, filed 14 May 2024.